Fresenius SE & Co KGaA FSNUF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FSNUF is a good fit for your portfolio.
News
-
Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease
-
Fresenius Shares Slump After Novo Nordisk Kidney Disease Trial Shows Efficacy
-
Fresenius Places Bonds With a Volume of EUR1 Billion
-
Fresenius cuts guidance again amid macroeconomic pressures and struggling North American unit
Trading Information
- Previous Close Price
- $25.77
- Day Range
- $30.47–30.47
- 52-Week Range
- $24.90–32.43
- Bid/Ask
- $28.08 / $34.53
- Market Cap
- $17.16 Bil
- Volume/Avg
- 412 / 1,425
Key Statistics
- Price/Earnings (Normalized)
- 9.79
- Price/Sales
- 0.59
- Dividend Yield
- 3.26%
- Dividend Yield (Forward)
- 3.53%
- Total Yield
- 3.26%
Company Profile
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Large Value
- Total Number of Employees
- 193,527
- Website
- https://www.fresenius.com
Competitors
Valuation
|
Metric
|
FSNUF
|
BAX
|
FMS
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.79 | 13.49 | 13.69 |
Price/Book Value | 0.81 | 2.28 | 0.80 |
Price/Sales | 0.59 | 1.24 | 0.57 |
Price/Cash Flow | 6.52 | 12.68 | 5.52 |
Price/Earnings
FSNUF
BAX
FMS
Financial Strength
|
Metric
|
FSNUF
|
BAX
|
FMS
|
|---|---|---|---|
Quick Ratio | 0.18 | 1.34 | 0.80 |
Current Ratio | 1.54 | 1.94 | 1.37 |
Interest Coverage | 4.55 | 1.16 | 3.13 |
Quick Ratio
FSNUF
BAX
FMS
Profitability
|
Metric
|
FSNUF
|
BAX
|
FMS
|
|---|---|---|---|
Return on Assets (Normalized) | 2.02% | 4.62% | 2.09% |
Return on Equity (Normalized) | 7.58% | 21.38% | 5.34% |
Return on Invested Capital (Normalized) | 3.46% | 7.35% | 3.39% |
Return on Assets
FSNUF
BAX
FMS
Medical Care Facilities Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Szxxv | $67.3 Bil | |
JDHIY
| JD Health International Inc ADR | Vzlvh | $16.3 Bil | |
BDUUF
| Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt | Prqyt | $11.8 Bil | |
BDULF
| Bangkok Dusit Medical Services PCL Shs Foreign Registered | Gjrdf | $11.8 Bil | |
FMS
| Fresenius Medical Care AG & Co. KGaA ADR | Fsnfgq | $11.8 Bil | |
DVA
| DaVita Inc | Plyswf | $9.1 Bil | |
THC
| Tenet Healthcare Corp | Pcdjx | $6.8 Bil | |
EHC
| Encompass Health Corp | — | $6.5 Bil | |
AMN
| AMN Healthcare Services Inc | Flwkpn | $2.5 Bil |